Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory

被引:57
作者
Ganz, PA
机构
[1] Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90095 USA
关键词
cancer survivors; late effects; registries; childhood leukaemia;
D O I
10.1016/S0959-8049(03)00489-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper provides a rationale for the importance of studying health outcomes in cancer survivors, including their growing numbers, the need for detailed information on the short and long-term effects of treatment, and the interactions of cancer with other comorbid conditions. However, there are a number of challenges associated with this research. Identification and recruitment of cancer survivors is not always easy, and linking their current health status to details of medical treatment is important, but not always feasible. National surveys and databases are a potential source of information on survivors, but may not provide sufficient details for this type of research. Strategies need to be developed to plan for long-term Outcome studies in cancer patients from the very beginning of treatment to obtain the most comprehensive data oil the outcomes of survivors. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2136 / 2141
页数:6
相关论文
共 57 条
[1]   Improved survival for patients with testicular cancer in Europe since 1978 [J].
Aareleid, T ;
Sant, M ;
Hédelin, G .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (14) :2236-2240
[2]   Second cancers after pediatric Hodgkin's disease [J].
Bhatia, S ;
Meadows, AT ;
Robison, LL .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2570-2571
[3]   Breast cancer and other second neoplasms after childhood Hodgkin's disease [J].
Bhatia, S ;
Robison, LL ;
Oberlin, O ;
Greenberg, M ;
Bunin, G ;
FossatiBellani, F ;
Meadows, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :745-751
[4]   Use of period analysis for providing more up-to-date estimates of long-term survival rates:: empirical evaluation among 370 000 cancer patients in Finland [J].
Brenner, H ;
Söderman, B ;
Hakulinen, T .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (02) :456-462
[5]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101
[6]  
Coebergh JW, 2001, EUR J CANCER, V37, pS217
[7]   Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years [J].
Dores, GM ;
Metayer, C ;
Curtis, RE ;
Lynch, CF ;
Clarke, EA ;
Glimelius, B ;
Storm, H ;
Pukkala, E ;
van Leeuwen, FE ;
Holowaty, EJ ;
Andersson, M ;
Wiklund, T ;
Joensuu, T ;
van't Veer, MB ;
Stovall, M ;
Gospodarowicz, M ;
Travis, LB .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) :3484-3494
[8]   Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden [J].
Edwards, BK ;
Howe, HL ;
Ries, LAG ;
Thun, MJ ;
Rosenberg, HM ;
Yancik, R ;
Wingo, PA ;
Jemal, A ;
Feigal, EG .
CANCER, 2002, 94 (10) :2766-2792
[9]   Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].
Fisher, B ;
Anderson, S ;
Bryant, J ;
Margolese, RG ;
Deutsch, M ;
Fisher, ER ;
Jeong, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1233-1241
[10]   Long-term renal function after treatment for malignant germ-cell tumours [J].
Fosså, SD ;
Aass, N ;
Winderen, M ;
Börmer, OP ;
Olsen, DR .
ANNALS OF ONCOLOGY, 2002, 13 (02) :222-228